David Gregornik, BS, PharmD, BCOP, Director, Pharmacogenomics Program, presented and moderated a panel discussion at the University of Minnesota Biennial Pharmacogenomics Conference. The event was held on Sept. 10-11 and focused on practical considerations for the implementation of pharmacogenomics into clinical care.
On Sept. 10, Dr. Gregornik was the moderator for the first session of the conference entitled “Implementation Science and Examples of Pharmacogenomics Implementations.” The five-speaker panel included an expert in Implementation Science and four clinicians who lead pharmacogenomics programs at their respective institutions:
• David Gregornik, BS, PharmD, BCOP, Children’s Minnesota
• Todd Sorensen, PharmD, FAPHA, FCCP, College of Pharmacy, University of Minnesota
• Cyrine Haidar, PharmD, BCPS, BCOP, St Jude Children’s Research Hospital
• Sara Van Driest, MD, PhD, Vanderbilt University
• April Schultz, PharmD, Sanford Health
After a primer on implementation science by Dr. Sorensen, the pharmacogenomics experts gave presentations describing unique features, successes and challenges each faced developing their respective programs. Dr. Gregornik’s presentation highlighted how implementation science was used to guide the development of the Children’s Minnesota program and the successful modifications made to the Children’s Minnesota electronic health record that provide point-of-care support to prescribers ordering medications with pharmacogenomic implications.
Later in the day, Dr. Gregornik also co-led a case discussion with Jacob Brown, PharmD, MS (College of Pharmacy, University of Minnesota-Duluth) entitled “Providing Pharmacogenomics-Guided Care in the Absence of Clinical Guidelines.” This session, for front line clinicians, provided a standardized approach to evaluating pharmacogenomic scientific evidence for direct patient care.
For future educational opportunities, visit Children’s Minnesota’s education and training page.
